The program that saved 26 million lives is being wound down by a strategy that opens by citing the 26 million lives.

The finding, in one paragraph: the largest commitment any nation has ever made to fight a single disease is being restructured around a deadline, and every document in the restructuring concedes the stakes.▸ The State Department's own strategy — the charter for the transition — opens with PEPFAR's numbers: 26 million lives saved, 7.8 million babies born without HIV, measurably faster GDP growth and less instability in the countries it serves. The same document commits the "majority of 71 U.S.-supported countries" to "full self-reliance" within the term of time-bound compacts, with the United States holding the right to withhold funds when benchmarks slip. Between the scorecard and the deadline sits the evidence of what interruption costs, produced in real time by the transition's first months: a peer-reviewed model counts the 2025 funding freeze's excess deaths in the tens of thousands across just seven countries, and UNAIDS's tracking records 2.5 million people losing access to prevention drugs, testing budgets down 22 percent, and condom funding down 93 percent in high-burden countries.

Five sources, each read directly.▸ The charter is the State Department's America First Global Health Strategy (September 2025, read in full) — the 26-million-lives scorecard, the 71-country transition, the withholding rights, the December 2025 compact deadline, all quoted from its pages. The epidemiology is the eClinicalMedicine modeling study of the funding freeze (April 2025) and UNAIDS's US-funding-impact tracking, drawing on 55-country real-time reporting and its 2025 Global AIDS Update. The capacity ledger is GAO's audited federal workforce count — USAID from 4,895 people to 258. The compact tallies (32 agreements, ≥$23.5 billion, ~39 percent recipient-funded) are the Center for Global Development's and Think Global Health's tracking of the State Department's announcements.

The strategy is not a repudiation — that is what makes it unusual.▸ It quotes the program's successes at length: the lives, the births, an independent assessment of faster GDP growth, a 40 percent reduction in political instability in PEPFAR countries versus 3 percent elsewhere. Its argument is that success should now be owned by the countries: compacts fund "100% of all frontline commodity" costs while transferring staffing and systems to governments on benchmarks, with U.S. funding withholdable when the benchmarks miss. Reasonable people designed it; the Bush Center called it "a step in the right direction." The cross-examination is not the design — it is the gap between the design's assumptions and the documented events running alongside it.

The freeze study's scenarios bracket what actually happened — waivers came, but slowly and unevenly — and its central lesson is about lag: treatment interruptions kill over years, not weeks, so the deaths from 2025's pause arrive through 2030 regardless of what follows.▸ UNAIDS's operational tracking fills in the mechanism: 2.5 million people off PrEP by October 2025, testing funding down 22 percent, condom funding down 93 percent in high-burden countries — prevention, the part of the response whose failures compound silently into the next decade's treatment rolls.

Three documented tensions.▸ Money without machinery. Congress went out of its way to protect PEPFAR's appropriation — the Senate stripped the program's $400 million from the July 2025 rescission before passage. But roughly half of PEPFAR's implementation ran through USAID, whose workforce is now 258 people, down from 4,895, by the government's own audited count. A protected budget line executed through a dissolved agency is the transition's actual operating condition, and no document reconciles the two. The two 2030s. The strategy's deadline — "full self-reliance during the term of the agreement" — and UNAIDS's projection — more than 4 million additional deaths by 2030 if PEPFAR-supported programs halt — are dated to the same year. Everything depends on whether the compacts' benchmarks track epidemiology or fiscal calendars; the withholding clause means a missed co-financing target in a country carrying millions of patients converts, mechanically, into the halt scenario for that country. The evidence of the opening months. The strategy assumes orderly transfer; the freeze that preceded it — abrupt, waiver-patched — produced the tens of thousands of modeled deaths above. The transition's first data point is the strongest argument its own documents contain for doing the rest of it slowly.

The compacts govern now: 32 signed, more negotiating, benchmarks and co-financing schedules mostly unpublished — their disclosure is the single most checkable transparency question in global health policy this year.▸ PEPFAR's statutory authorization remains lapsed (since March 2025), leaving the program running on appropriations and the strategy's administrative architecture. UNAIDS's July updates and PEPFAR's own results reporting will show treatment numbers through the first compact year; the eClinicalMedicine lag-structure means 2026–2028 mortality data grades the 2025 freeze, whatever else improves.

The strategy, the modeling study, the UNAIDS tracking, and the GAO workforce count were read directly; compact tallies are the CGD and Think Global Health records of State's announcements. Modeled deaths are projections with stated uncertainty intervals, not observed counts; UNAIDS's 4-million figure describes a full-halt scenario, not current policy. PEPFAR's treatment total is its published results figure.